HomeBUSINESS
BUSINESS

Drug Maker Downsizing Shows No Sign of Stopping; Boehringer to Ax 300 Jobs, while Shionogi Sees “Tremendous Reduction” in Rep Numbers
(May.31.2018)

By Reiji Anasako

Drug makers in Japan are accelerating their moves to slim down their workforce as they face an imperative to streamline their operations amid drug pricing overhauls. Nippon Boehringer Ingelheim has embarked on a sharp job cut, while Shionogi is retooling its sales structure at home, with Astellas Pharma and Taisho Pharmaceutical Holdings launching voluntary redundancy programs ...
(LOG IN FOR FULL STORY)